Delivery Order SPE2DB20D1100-SPE2DB25FE1DX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Sunitinib Malate 37.5 mg capsules (28-count units) with a ceiling value of $11,228.08. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an existing indefinite delivery contract vehicle. The contract specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025, and...
- The Defense Logistics Agency awarded a $35,205.19 delivery order to AmerisourceBergen Drug Corp for Sunitinib Malate 25 mg capsules (28-count packaging) on September 12, 2025, with an ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be performed and shipped...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Sunitinib Malate 50 mg capsules (28-count packages) with a ceiling value of $22,358.72. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Sunitinib Malate 37.5 mg capsules (28-count) with a ceiling value of $9,141.79. This is a firm fixed price delivery order with no set-aside designation, completed competitively. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Sunitinib Malate 50 mg capsules (quantity 28) with a ceiling value of $11,179.35. This firm fixed price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 pharmaceutical prime vendor agreement running through December 2026. The contract...
- This is a delivery order from the Defense Logistics Agency (DLA) awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Sunitinib Malate 25 mg capsules. The order, valued at $37,567.48, has a firm fixed price pricing type and an ultimate completion date of August 14, 2024. The contract does not have a set-aside designation. As a large pharmaceutical supplier, AmerisourceBergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,265.28 firm fixed-price delivery order is for the supply of 4,567,116,751 units of the 25 mg capsule form of the drug Sunitinib Malate. This order does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of the pharmaceutical product Sunitinib Malate 37.5 mg capsules. The total contract ceiling value is $10,073.85, with an ultimate completion date of April 3, 2024. This delivery order contract is one of several that Amerisourcebergen Drug Corp holds with DLA to provide...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,230.85, is for the delivery of sunitinib malate 37.5 mg capsules, a medication used to treat certain types of cancer. The contract is a Firm Fixed Price Delivery Order, with a period of performance running through March 2025. The contract does not have a set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,347.29, is for the delivery of Sunitinib Malate 37.5 mg capsules. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1DXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $37,245.18 to AmerisourceBergen Drug Corp for the supply of Sunitinib Malate 25 mg capsules (28-count units). This competitively awarded contract, issued on September 25, 2025, with a completion date of September 26, 2025, represents a firm fixed price delivery order with no set-aside designation. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company maintains an extensive portfolio of pharmaceutical and medical supply delivery orders covering multiple therapeutic domains, from specialty medications to generic drugs and medical devices. This specific delivery order for Sunitinib Malate, an oncology medication, exemplifies the company's role in supplying critical pharmaceutical products to support Defense Health Agency operations and other federal healthcare systems. All reviewed contract awards with AmerisourceBergen have been competitively awarded with firm fixed pricing, demonstrating the company's capability to meet federal procurement requirements in open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.2k | 9/25/25 |